Cadence Builds Case For Branded IV Acetaminophen; Can It Reduce Opioid Use?

After rebounding from regulatory setbacks, Cadence Pharmaceuticals Inc. intravenous acetaminophen Ofirmev has been approved by FDA with a label many analysts praise as broad and positive.